324 related articles for article (PubMed ID: 12389073)
1. Effect of grapefruit juice intake on etoposide bioavailability.
Reif S; Nicolson MC; Bisset D; Reid M; Kloft C; Jaehde U; McLeod HL
Eur J Clin Pharmacol; 2002 Oct; 58(7):491-4. PubMed ID: 12389073
[TBL] [Abstract][Full Text] [Related]
2. Clinical pharmacology of chronic oral etoposide in patients with small cell and non-small cell lung cancer.
Zucchetti M; Pagani O; Torri V; Sessa C; D'Incalci M; De Fusco M; de Jong J; Gentili D; Martinelli G; Tinazzi A
Clin Cancer Res; 1995 Dec; 1(12):1517-24. PubMed ID: 9815952
[TBL] [Abstract][Full Text] [Related]
3. Coadministration of grapefruit juice increases systemic exposure of diltiazem in healthy volunteers.
Christensen H; Asberg A; Holmboe AB; Berg KJ
Eur J Clin Pharmacol; 2002 Nov; 58(8):515-20. PubMed ID: 12451428
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic comparison of oral and intravenous etoposide in patients treated with the CHOEP-regimen for malignant lymphomas.
Kroschinsky FP; Friedrichsen K; Mueller J; Pursche S; Haenel M; Prondzinsky R; Ehninger G; Schleyer E
Cancer Chemother Pharmacol; 2008 Apr; 61(5):785-90. PubMed ID: 17579865
[TBL] [Abstract][Full Text] [Related]
5. Effect of grapefruit juice volume on the reduction of fexofenadine bioavailability: possible role of organic anion transporting polypeptides.
Dresser GK; Kim RB; Bailey DG
Clin Pharmacol Ther; 2005 Mar; 77(3):170-7. PubMed ID: 15735611
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic modulation of oral etoposide by ketoconazole in patients with advanced cancer.
Yong WP; Desai AA; Innocenti F; Ramirez J; Shepard D; Kobayashi K; House L; Fleming GF; Vogelzang NJ; Schilsky RL; Ratain MJ
Cancer Chemother Pharmacol; 2007 Nov; 60(6):811-9. PubMed ID: 17308893
[TBL] [Abstract][Full Text] [Related]
7. Interaction between grapefruit juice and midazolam in humans.
Kupferschmidt HH; Ha HR; Ziegler WH; Meier PJ; Krähenbühl S
Clin Pharmacol Ther; 1995 Jul; 58(1):20-8. PubMed ID: 7628179
[TBL] [Abstract][Full Text] [Related]
8. Itraconazole increases but grapefruit juice greatly decreases plasma concentrations of celiprolol.
Lilja JJ; Backman JT; Laitila J; Luurila H; Neuvonen PJ
Clin Pharmacol Ther; 2003 Mar; 73(3):192-8. PubMed ID: 12621384
[TBL] [Abstract][Full Text] [Related]
9. Grapefruit juice increases oral nimodipine bioavailability.
Fuhr U; Maier-Brüggemann A; Blume H; Mück W; Unger S; Kuhlmann J; Huschka C; Zaigler M; Rietbrock S; Staib AH
Int J Clin Pharmacol Ther; 1998 Mar; 36(3):126-32. PubMed ID: 9562227
[TBL] [Abstract][Full Text] [Related]
10. Disposition of intravenous and oral cyclosporine after administration with grapefruit juice.
Ducharme MP; Warbasse LH; Edwards DJ
Clin Pharmacol Ther; 1995 May; 57(5):485-91. PubMed ID: 7768070
[TBL] [Abstract][Full Text] [Related]
11. Repeated consumption of grapefruit juice considerably increases plasma concentrations of cisapride.
Kivistö KT; Lilja JJ; Backman JT; Neuvonen PJ
Clin Pharmacol Ther; 1999 Nov; 66(5):448-53. PubMed ID: 10579471
[TBL] [Abstract][Full Text] [Related]
12. [Pharmacokinetic aspects of oral administration of etoposide].
Tillmann B; Krümpelmann S; Würthwein G; Wagner A; Schulze-Westhoff P; Hempel G; Jürgens H; Boos J
Klin Padiatr; 1998; 210(4):159-64. PubMed ID: 9743946
[TBL] [Abstract][Full Text] [Related]
13. Lack of effect of grapefruit juice on diltiazem bioavailability in normal subjects.
Sigusch H; Henschel L; Kraul H; Merkel U; Hoffmann A
Pharmazie; 1994 Sep; 49(9):675-9. PubMed ID: 7972311
[TBL] [Abstract][Full Text] [Related]
14. Grapefruit juice interaction with oral budesonide: equal effect on immediate-release and delayed-release formulations.
Seidegård J; Randvall G; Nyberg L; Borgå O
Pharmazie; 2009 Jul; 64(7):461-5. PubMed ID: 19694184
[TBL] [Abstract][Full Text] [Related]
15. Grapefruit juice-nifedipine interaction: possible involvement of several mechanisms.
Odou P; Ferrari N; Barthélémy C; Brique S; Lhermitte M; Vincent A; Libersa C; Robert H
J Clin Pharm Ther; 2005 Apr; 30(2):153-8. PubMed ID: 15811168
[TBL] [Abstract][Full Text] [Related]
16. Crossover clinical study comparing the pharmacokinetics of etoposide (75 mg) administered as 25-mg capsules three times a day versus once a day.
Aydiner A; Koyuncu H; Tas F; Topuz E; Disci R
Int J Clin Pharmacol Res; 2000; 20(1-2):21-30. PubMed ID: 11146899
[TBL] [Abstract][Full Text] [Related]
17. Intestinal drug transporter expression and the impact of grapefruit juice in humans.
Glaeser H; Bailey DG; Dresser GK; Gregor JC; Schwarz UI; McGrath JS; Jolicoeur E; Lee W; Leake BF; Tirona RG; Kim RB
Clin Pharmacol Ther; 2007 Mar; 81(3):362-70. PubMed ID: 17215845
[TBL] [Abstract][Full Text] [Related]
18. Validation of a limited sampling model to determine etoposide area under the curve.
Lum BL; Lane KJ; Synold TW; Goram A; Charnick SB; Sikic BI
Pharmacotherapy; 1997; 17(5):887-90. PubMed ID: 9324178
[TBL] [Abstract][Full Text] [Related]
19. Oral bioavailability of etoposide after administration of a single dose to tumor-bearing dogs.
Flory AB; Rassnick KM; Balkman CE; Kiselow MA; Autio K; Beaulieu BB; Lewis LD
Am J Vet Res; 2008 Oct; 69(10):1316-22. PubMed ID: 18828689
[TBL] [Abstract][Full Text] [Related]
20. Grapefruit juice has minimal effects on plasma concentrations of lovastatin-derived 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors.
Rogers JD; Zhao J; Liu L; Amin RD; Gagliano KD; Porras AG; Blum RA; Wilson MF; Stepanavage M; Vega JM
Clin Pharmacol Ther; 1999 Oct; 66(4):358-66. PubMed ID: 10546919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
